StockNews.AI
TCMD
StockNews.AI
195 days

Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025

1. TCMD will release Q4 and FY 2024 financial results on February 18. 2. A conference call will follow the results, enhancing investor communication. 3. Tactile Medical develops home therapies for chronic conditions, improving patients' lives. 4. There is a focus on reducing healthcare costs and increasing access to care. 5. Clinical collaboration aims to boost awareness about under-managed chronic disorders.

Earnings
-2.94%Current Return
VS
+0.34%S&P 500
$17.6902/05 04:15 PM EDTEvent Start
$17.1702/06 10:57 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Neutral?

Upcoming financial results could influence stock but are expectedly stable based on prior calls.

How important is it?

Earnings release is significant for valuation adjustments, but not a game-changer.

Why Short Term?

Immediate impact expected post-results announcement, reflected by market's typical responses to earnings.

Related Companies

TCMD
February 05, 2025 16:05 ET  | Source: Tactile Systems Technology, Inc. MINNEAPOLIS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2024 financial results will be released after the market closes on Tuesday, February 18, 2025. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on February 18, 2025, to discuss the results of the quarter and fiscal year. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13751026. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com. For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13751026. The webcast will be archived at investors.tactilemedical.com. About Tactile Systems Technology, Inc. (DBA Tactile Medical) Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year. Investor Inquiries:Sam BentzingerGilmartin Groupinvestorrelations@tactilemedical.com

Related News